With funding from the Global Genes’ Continuity of Care RARE Patient Impact Grant, the APS Type 1 Foundation is offering grants to APS1 Households Impacted by COVID-19.
COVID-19 has had widespread impacts throughout our communities in more ways than we can know. What do know, however, is that COVID-19’s impact on the rare disease community is real and profound. We are all living with the uncertainty of how COVID-19 will impact the most vulnerable among us and are taking extra precautions to protect our families. We want to help ease that burden just a bit.
The Foundation is the proud recipient of funds from Global Genes that are intended to be shared with those APS Type 1 households who have extra expenses during these difficult times. Individuals (or parent/guardian of a minor) living in the United States with a confirmed medical diagnosis of APS Type 1 are eligible to apply. Examples of what this grant could be used for include: telehealth access (includes access to resources that enable the family to conduct telehealth physical and mental health appointments), social support access (includes access to resources and tools for psych/social connectivity), educational needs (includes distance learning, tutoring, home school or school at home access), and career counseling (includes access to resources and tools).
Limited funds are available, so we encourage you to apply soon. While there is no firm deadline for your application, we will start to review all applications on June 8, 2020 with the goal of making awards by June 15, 2020. If you are interested in applying for this grant or would like to receive additional information, email us at email@example.com. The grant application can be found here.
To learn more about Global Genes, visit here.